NIKA PHARMACEUTICALS, INC Quarterly Return On Equity in % from Q4 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Nika Pharmaceuticals, Inc quarterly/annual Return On Equity history and growth rate from Q4 2021 to Q2 2024.
  • Nika Pharmaceuticals, Inc Return On Equity for the quarter ending June 30, 2024 was 75.3 %, a 55.4% decline year-over-year.
  • Nika Pharmaceuticals, Inc annual Return On Equity for 2023 was 100 %, a 99.9% decline from 2022.
  • Nika Pharmaceuticals, Inc annual Return On Equity for 2022 was 82.6K %, a 106823% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 75.3 -93.5 -55.4% Apr 1, 2024 Jun 30, 2024
Q1 2024 99.7 -24.3K -99.6% Jan 1, 2024 Mar 31, 2024
Q4 2023 100 -82.5K -99.9% Oct 1, 2023 Dec 31, 2023
Q3 2023 113 -58.7K -99.8% Jul 1, 2023 Sep 30, 2023
Q2 2023 169 -31.9K -99.5% Apr 1, 2023 Jun 30, 2023
Q1 2023 24.4K +24.2K +13906% Jan 1, 2023 Mar 31, 2023
Q4 2022 82.6K +82.5K +106823% Oct 1, 2022 Dec 31, 2022
Q3 2022 58.8K Jul 1, 2022 Sep 30, 2022
Q2 2022 32K Apr 1, 2022 Jun 30, 2022
Q1 2022 174 Jan 1, 2022 Mar 31, 2022
Q4 2021 77.2 Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.